We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
(+7.6%)
Cap. Flow
+$567M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$82.7M |
| 2 |
PepsiCo
PEP
|
+$76.8M |
| 3 |
Marriott International
MAR
|
+$64.8M |
| 4 |
Tyson Foods
TSN
|
+$62.8M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$64.8M |
| 2 |
Hormel Foods
HRL
|
+$61.4M |
| 3 |
Gilead Sciences
GILD
|
+$59.9M |
| 4 |
Hilton Worldwide
HLT
|
+$54.7M |
| 5 |
TechnipFMC
FTI
|
+$51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.71% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PBCT
501
DELISTED
People's United Financial Inc
PBCT
| $2.74M | 0.02% |
173,545
-101,321
| -37% | -$1.57M |
|
502
Trane Technologies
TT
$106B
| $2.73M | 0.02% |
40,264
+18,902
| +88% | +$1.26M |
|
503
Vanguard Information Technology ETF
VGT
$139B
| $2.73M | 0.02% |
181,536
-12,272
| -6% | -$178K |
|
504
Vanguard Large-Cap ETF
VV
$51.9B
| $2.72M | 0.02% |
27,415
-1,715
| -6% | -$170K |
|
505
Delta Air Lines
DAL
$55.9B
| $2.7M | 0.02% |
68,721
-111,819
| -62% | -$4.23M |
|
|
TCF
506
DELISTED
TCF Financial Corporation
TCF
| $2.7M | 0.02% |
+185,960
| New | +$2.58M |
|
507
Arrow Electronics
ARW
$10.9B
| $2.69M | 0.02% |
42,003
-632
| -1% | -$40.8K |
|
|
XIFR
508
XPLR Infrastructure LP
XIFR
$1.18B
| $2.68M | 0.02% |
95,994
+5,460
| +6% | +$165K |
|
509
C.H. Robinson
CHRW
$22B
| $2.68M | 0.02% |
38,081
-255
| -0.7% | -$17.9K |
|
510
Genpact
G
$5.3B
| $2.67M | 0.02% |
111,461
| – | – |
|
511
Pitney Bowes
PBI
$2.42B
| $2.66M | 0.02% |
146,449
-962
| -0.7% | -$17.7K |
|
512
Macy's
M
$6.15B
| $2.65M | 0.02% |
71,663
-30,454
| -30% | -$1.1M |
|
513
Morgan Stanley
MS
$337B
| $2.64M | 0.01% |
82,477
+73,735
| +843% | +$2.2M |
|
514
Regeneron Pharmaceuticals
REGN
$68.8B
| $2.63M | 0.01% |
6,539
+211
| +3% | +$84.6K |
|
|
AIV
515
Aimco
AIV
$380M
| $2.61M | 0.01% |
427,355
-1,276
| -0.3% | -$7.68K |
|
516
Vanguard Mid-Cap ETF
VO
$106B
| $2.61M | 0.01% |
80,652
+40
| +0% | +$1.28K |
|
517
Ameren
AEE
$31.5B
| $2.59M | 0.01% |
52,662
+36,022
| +216% | +$1.84M |
|
518
iShares MSCI EAFE Value ETF
EFV
$27.6B
| $2.58M | 0.01% |
55,895
-3,486
| -6% | -$157K |
|
519
iShares S&P 500 Growth ETF
IVW
$72.5B
| $2.54M | 0.01% |
83,548
| – | – |
|
|
TEN
520
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $2.49M | 0.01% |
42,683
-365,041
| -90% | -$19.9M |
|
|
WP
521
DELISTED
Worldpay, Inc.
WP
| $2.47M | 0.01% |
43,991
+33,906
| +336% | +$1.88M |
|
522
State Street
STT
$50.9B
| $2.45M | 0.01% |
35,183
-1,692
| -5% | -$111K |
|
523
Targa Resources
TRGP
$60.4B
| $2.4M | 0.01% |
48,934
+44,717
| +1,060% | +$1.94M |
|
|
BHI
524
DELISTED
Baker Hughes
BHI
| $2.4M | 0.01% |
47,513
+36,728
| +341% | +$1.77M |
|
|
FLG
525
Flagstar Bank National Association
FLG
$5.77B
| $2.38M | 0.01% |
55,862
-517,439
| -90% | -$22.7M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2016 Portfolio in Review
As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.
- Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
- Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
- Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
- Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
- Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
- Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
- Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.
Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.